Daily non-political popular news in brief.

Discovery of the oldest adornments in the world

06-18-2007 · EurekAlert!

The discovery of small perforated sea shells in eastern Morocco has shown that the use of bead adornments in North Africa is older than thought, dating to 82,000 years ago. As adornments, together with art, burial and the use of pigments, are considered to be among the most conclusive signs of the acquisition of symbolic thought and of modern cognitive abilities, this study is leading researchers to question their ideas about the origins of modern humans.

Keywords: discovery, oldest, adornments, world, adornment

« Previous | Next »

Similar news on "Discovery of the oldest adornments in the world":

The world's oldest bacteria
08-27-2007 · EurekAlert!
A research team has for the first time ever discovered DNA from living bacteria that are more than half a million years old. Never before has traces of still living organisms that old been found. The exceptional discovery can lead to a better understanding of the ageing of cells and might even cast light on the question of life on Mars.
Similar news · Read more »
World's oldest ritual discovered
11-30-2006 · EurekAlert!
A new archaeological find in Botswana by an archaeologist from the University from Oslo shows that our ancestors in Africa engaged in ritual practice 70,000 years ago -- 30,000 years earlier than the oldest finds in Europe. This sensational discovery strengthens Africa's position as the cradle of modern man.
Similar news · Read more »
How fish punish 'queue jumpers'
06-26-2007 · EurekAlert!
Fish use the threat of punishment to keep would-be jumpers in the mating queue firmly in line and the social order stable, a new study led by Australian marine scientists has found.Their discovery, which has implications for the whole animal kingdom including humans, has been hailed by some of the world's leading biologists as a "must read" scientific paper and published in the Proceedings of the Royal Society of London Series B.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Forest Primeval: The oldest known trees finally gain a crown
04-21-2007 · Science News Online
Recently unearthed fossils provide new insights about the appearance of the world's oldest known trees, plants that previously were known only from preserved stumps.
Similar news · Read more »
New gene linked to macular degeneration risk
10-19-2006 · EurekAlert!
Researchers at the John A. Moran Eye Center at the University of Utah have identified a gene called HTRA1 that contributes to a major risk of age related macular degeneration, the most common cause of irreversible vision loss in the developed world. The discovery of this gene allows anyone to take a simple blood test to find out if they are up to 700 percent more likely to develop AMD than the average person.
Similar news · Read more »
New discovery may improve treatment of one of the world's leading causes of blindness
09-28-2007 · EurekAlert!
An inflammatory eye condition that is one of the world's leading causes of blindness could be treated much more effectively and easily thanks to a new discovery. In experiments with laboratory rats, scientists at the University of Texas Medical Branch at Galveston have developed a potential new therapy for uveitis -- the inflammation of the uvea, a layer of tissue that lies just below the outer surface of the eyeball and includes the iris.
Similar news · Read more »
Discovery could lead to better control of hemorrhagic fever viruses
02-07-2007 · EurekAlert!
Researchers report discovering the receptor through which a group of life-threatening hemorrhagic fever viruses enter and attack the body's cells, and show that infection can be inhibited by blocking this receptor. The findings, to be published online by the journal Nature on Feb. 7, give a clue to the high lethality of New World arenaviruses, suggest a way of reducing the severity of infection, and point the way toward a sorely needed treatment strategy.
Similar news · Read more »
Targeting nerve growth factor may cure liver cancer
09-19-2007 · EurekAlert!
Biologists led by Dr. Serafino from the National Research Council of Italy published their surprising discovery that NGF and its receptor were aberrantly expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma. These two molecules are not expressed in the liver of healthy people. Published in the Oct. 7 issue of the World Journal of gastroenterology, this article brings a bright future for devising a cure for HCC.
Similar news · Read more »
Targeting nerve growth factor may cure liver cancer
09-05-2007 · EurekAlert!
Biologists led by Dr. Serafino from the National Research Council of Italy published their surprising discovery that NGF and its receptor were aberrantly expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma (HCC). These two molecules are not expressed in the liver of healthy people. Published in the October 7 issue of the World Journal of gastroenterology, this article brings a bright future for devising a cure for HCC.
Similar news · Read more »